$15 million for dementia research

$15 million for dementia research

Illuminate newsletter index page, June 2019
June 2019

Professor Doug Hilton and Professor Christine Kilpatrick.
Institute director Professor Doug Hilton and CEO of Melbourne
Health and The Royal Melbourne Hospital, Professor Christine
Kilpatrick.

Vital research to address the growing burden of dementia in Australia has been given a significant boost with $15 million over five years from the Colonial Foundation.

The grant will establish the Colonial Foundation Healthy Ageing Centre led by the Institute and The Royal Melbourne Hospital.

An Australian first, the centre will bring together leading clinicians, pathologists and researchers with the goal of developing diagnostic tests for the early detection of neurodegenerative conditions that could cause dementia in people as young as 40.

Early detection for prevention

Dementia is a major health challenge in Australia. In 2016, one in 10 people aged over 65 were diagnosed with the condition. Without breakthroughs in diagnostics and therapies, the number of dementia patients is expected to more than double by 2050.

Early detection of the disease is crucial because by the time symptoms occur, most of the damage cannot be reversed.

Collaboration key to progress

Institute director Professor Doug Hilton said the new centre could lead to exciting advances at the frontier of ageing.

“The Colonial Foundation Healthy Ageing Centre will provide a platform for harnessing the latest technology and collaborative power of experts."

“The important biological insights gained from this collaborative research could lead to the development of therapies that halt or slow the progression of dementia,” he said.

Super Content: 
View of neural stem cells

Learn about our research into the causes of neurodegenerative disorders, and our work to develop new treatments for these conditions.

Art of Science image of inflammation

We are revealing how inflammation is controlled, and advancing the diagnosis and treatment of inflammatory diseases.